Inspire Investing’s Celyad Oncology SA American Depositary Shares CYAD Stock Holding History

Inspire Investing’s Portfolio CYAD Stock Details CYAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-38	Closed	–	–	759
2020 Q1	$0	Buy	+38	New	+$361	﹤0.01%	815
2018 Q1	–	Sell	-21	Closed	-$1K	–	770
2017 Q4	$1K	Buy	+21	New	+$1.05K	﹤0.01%	903

Other funds holding CYAD

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Inspire Investing's CYAD Position: Q2 2020 in Review

Inspire Investing sold out of Celyad Oncology SA American Depositary Shares (CYAD) in Q2 2020, closing a stake of 38 shares.

Inspire Investing first reported a position in CYAD in Q4 2017 and held it in 2 quarters. The position peaked at $1K in Q4 2017. 9 funds tracked by Wall St. Rank hold CYAD as of Q2 2020.

Inspire Investing reported no remaining Celyad Oncology SA American Depositary Shares position as of Q2 2020 after selling out during the quarter.
Inspire Investing sold 38 Celyad Oncology SA American Depositary Shares shares in Q2 2020.
Inspire Investing first reported a position in Celyad Oncology SA American Depositary Shares in Q4 2017 and held it in 2 quarters.
Inspire Investing's Celyad Oncology SA American Depositary Shares position peaked at $1K in Q4 2017.
9 funds tracked by Wall St. Rank held Celyad Oncology SA American Depositary Shares as of Q2 2020.

Based on Inspire Investing's 13F filing for Q2 2020, filed 12 Aug 2020.